Cantor Fitzgerald, Phat and Overweight Recommendation
Cantor Fitzgerald adjusted its outlook on Informatica (NYSE:INFA) shares by lowering the price target to $18.00 from the ...
CVS Health (CVS) stock was upgraded by Cantor Fitzgerald to Overweight after the company posted strong Q4 results earlier in ...
Stock analysts at Cantor Fitzgerald issued their FY2025 earnings per share estimates for Axsome Therapeutics in a note issued ...
It’s not that the Trump administration is anti-Goldman Sachs, sources say, but rather there just isn’t as much talent to take ...
A U.S. Senate committee voted on Wednesday to advance President Donald Trump's nominee Howard Lutnick, billionaire chairman ...
Cantor Fitzgerald Investment Advisors L.P. decreased its stake in shares of Meta Platforms, Inc. (NASDAQ:META – Free Report) by 1.6% in the fourth quarter, according to its most recent 13F filing with ...
“As you can imagine, the pain we suffered with Gary and 657 of my other friends and colleagues at Cantor Fitzgerald were killed on 9/11,” Lutnick said during his confirmation hearing before ...
Cantor Fitzgerald raised the firm’s price target on Protolabs (PRLB) to $50 from $40 and keeps an Overweight rating on the shares. Protolabs reported better-than-expected revenue and adjusted ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback